1. Home
  2. IRON vs PJT Comparison

IRON vs PJT Comparison

Compare IRON & PJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$80.40

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Logo PJT Partners Inc.

PJT

PJT Partners Inc.

HOLD

Current Price

$172.31

Market Cap

3.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
PJT
Founded
2017
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IRON
PJT
Price
$80.40
$172.31
Analyst Decision
Strong Buy
Hold
Analyst Count
13
4
Target Price
$108.85
$190.33
AVG Volume (30 Days)
646.9K
234.4K
Earning Date
11-06-2025
02-03-2026
Dividend Yield
N/A
0.58%
EPS Growth
N/A
72.84
EPS
N/A
6.53
Revenue
N/A
$1,657,789,000.00
Revenue This Year
N/A
$15.24
Revenue Next Year
N/A
$10.85
P/E Ratio
N/A
$26.37
Revenue Growth
N/A
23.30
52 Week Low
$30.82
$119.76
52 Week High
$99.50
$190.28

Technical Indicators

Market Signals
Indicator
IRON
PJT
Relative Strength Index (RSI) 35.05 52.64
Support Level $71.41 $169.42
Resistance Level $92.00 $173.68
Average True Range (ATR) 4.40 4.03
MACD -1.73 0.08
Stochastic Oscillator 31.96 33.85

Price Performance

Historical Comparison
IRON
PJT

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services and others. Geographically, It generates a majority of its revenue from the United States.

Share on Social Networks: